Neural KCNQ (Kv7) channels

British Journal of Pharmacology

Volumn 156, Issue 8, 2009, Pages 1185-1195

  Brown, David A ^a   Passmore, Gayle M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Action potentials; Analgesic; Anticonvulsant; Excitability; Hippocampal neurons; M channels; Muscarinic receptors; Potassium channels; Sensory systems; Sympathetic neurons

Indexed keywords

10,10 BIS(4 PYRIDINYLMETHYL) 9(10H) ANTHRACENONE; FLUPIRTINE; KV CHANNEL INTERACTING PROTEIN; KV CHANNEL INTERACTING PROTEIN 7; KV CHANNEL INTERACTING PROTEIN 7.1; KV CHANNEL INTERACTING PROTEIN 7.2; KV CHANNEL INTERACTING PROTEIN 7.3; LINOPIRDINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M3 RECEPTOR; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPASE C; POTASSIUM CHANNEL KCNQ4; POTASSIUM CHANNEL KCNQ5; RETIGABINE; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CHOLINERGIC ACTIVITY; CHRONIC PAIN; CONTROLLED STUDY; ENZYME ACTIVATION; GENE; GENE DISRUPTION; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HYDROLYSIS; INFLAMMATION; KCNQ GENE; KCNQ2 GENE; MOUSE; NERVE CELL EXCITABILITY; NEUROMODULATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; REVIEW; SENSORY SYSTEM; SYMPATHETIC NERVE;

ACETYLCHOLINE; ACTION POTENTIALS; ADRENERGIC FIBERS; ANALGESICS; ANIMALS; ANTICONVULSANTS; CA1 REGION, HIPPOCAMPAL; HUMANS; ION CHANNEL GATING; KCNQ POTASSIUM CHANNELS; MUSCARINIC AGONISTS; NEURONS; POTASSIUM; POTASSIUM CHANNEL BLOCKERS; PYRAMIDAL CELLS; RECEPTORS, MUSCARINIC; SENSORY RECEPTOR CELLS; SYNAPTIC TRANSMISSION;

EID: 68749110672     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00111.x     Document Type: Review

References (83)

1. Adams PR, Jones SW, Pennefather P, Brown DA, Kock C, Lancaster B (1986). Slow synaptic transmission in frog sympathetic ganglia. J Exp Biol 124 : 259 285.
2. Aiken SP, Lampe BJ, Murphy PA, Brown BS (1995). Reduction of spike frequency adaptation and blockade of M-current in rat CA1 pyramidal neurones by linopirdine (DuP 996), a neurotransmitter release enhancer. Br J Pharmacol 115 : 1163 1168.
3. Aiken SP, Zaczek R, Brown BS (1996). Pharmacology of the neurotransmitter release enhancer linopirdine (DuP 996), and insights into its mechanism of action. Adv Pharmacol 35 : 349 384.
4. Bentzen BH, Schmitt N, Calloe K, Dalby Brown W, Grunnet M, Olesen SP (2006). The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels. Neuropharmacology 51 : 1068 1077.
5. Blackburn-Munro G, Jensen BS (2003). The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain. Eur J Pharmacol 460 : 109 116.
6. Brown DA (1983). Slow cholinergic excitation - a mechanism for increasing neuronal excitability. Trends Neurosci 6 : 302 306.
7. Brown DA (1986). Voltage-sensitive ion channels mediating modulatory effects of acetylcholine, amines and peptides. In : Iversen LL, Goodman E (eds). Fast and Slow Chemical Signalling in the Nervous System. Oxford University Press : Oxford, pp. 130 150.
8. Brown DA (1988). M currents. In : Narahashi T (ed.). Ion Channels, Vol. 1. Plenum Press : New York, pp. 55 99.
9. +-current in a vertebrate neurone. Nature 283 : 673 676.
10. Brown DA, Selyanko AA (1985). Membrane currents underlying the slow excitatpry post-synaptic potential in the rat sympathetic ganglion. J Physiol 365 : 335 364.
11. Cassell JF, McLachlan EM (1987). Muscarinic agonists block five different potassium conductances in guinea-pig sympathetic neurones. Br J Pharmacol 91 : 259 261.
12. Chen S, Yaari Y (2008). Spike Ca2+ influx upmodulates the spike afterdepolarization and bursting via intracellular inhibition of KV7/M channels. J Physiol 586 : 1351 1363.
13. Chung HJ, Jan YN, Jan LY (2006). Polarized axonal surface expression of neuronal KCNQ channels is mediated by multiple signals in theKCNQ2andKCNQ3C- terminal domains. Proc Natl Acad Sci USA 103 : 8870 8875.
14. Dencker D, Dias R, Pedersen ML, Husum H (2008). Effect of the new antiepileptic drug retigabine in a rodent model of mania. Epilepsy Behav 12 : 49 53.
15. Devaux JJ, Kleopa KA, Cooper EC, Scherer SS (2004). KCNQ2 is a nodal K+ channel. J Neurosci 24 : 1236 1244.
16. Dost R, Rostock A, Rundfeldt C (2004). The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation. Naunyn Schmiedebergs Arch Pharmacol 369 : 382 390.
17. Dubois JM (1981). Evidence for the existence of three types of potassium channels in the frog Ranvier node membrane. J Physiol 318 : 297 316.
18. Friedel HA, Fitton A (1993). Flupirtine. A review of its pharmacological properties, and therapeutic efficacy in pain states. Drugs 45 : 548 569.
19. Gribkoff VK (2008). The therapeutic potential of neuronal Kv7 (KCNQ) channel modulators: an update. Expert Opin Ther Targets 12 : 565 581.
20. Hadley JK, Passmore GM, Tatulian L, Al-Qatari M, Ye F, Wickenden AD et al. (2003). Stoichiometry of expressed KCNQ2/KCNQ3 channels and subunit composition of native ganglionic M-channels deduced from block by tetraethylammonium (TEA). J Neurosci 23 : 5012 5019.
21. Halliwell JV, Adams PR (1982). Voltage-clamp analysis of muscarinic excitation in hippocampal neurons. Brain Res 250 : 71 92.
22. Hansen HH, Andreasen JT, Weikop P, Mirza N, Scheel-Krüger J, Mikkelsen JD (2007). The neuronal KCNQ channel opener retigabine inhibits locomotor activity and reduces forebrain excitatory responses to the psychostimulants cocaine, methylphenidate and phencyclidine. Eur J Pharmacol 570 : 77 88.
23. Hansen HH, Waroux O, Seutin V, Jentsch TJ, Aznar S, Mikkelsen JD (2008). Kv7 channels: interaction with dopaminergic and serotonergic neurotransmission in the CNS. J Physiol 586 : 1823 1832.
24. Hernandez CC, Zaika O, Shapiro MS (2008). A carboxy-terminal inter-helix linker as the site of phosphatidylinositol 4,5-bisphosphate action on Kv7 (M-type) K+ channels. J Gen Physiol 132 : 361 381.
25. Hughes S, Marsh SJ, Tinker A, Brown DA (2007). PIP(2)-dependent inhibition of M-type (Kv7.2/7.3) potassium channels: direct on-line assessment of PIP(2) depletion by Gq-coupled receptors in single living neurons. Pflugers Arch 455 : 115 124.
26. Jentsch TJ (2000). Neuronal KCNQ potassium channels: physiology and role in disease. Nat Rev Neurosci 1 : 21 30.
27. Kawai T, Watanabe M (1986). Blockade of Ca-activated K conductance by apamin in rat sympathetic neurones. Br J Pharmacol 87 : 225 232.
28. Korsgaard MP, Hartz BP, Brown WD, Ahring PK, Strøbaek D, Mirza NR (2005). Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels. J Pharmacol Exp Ther 314 : 282 292.
29. Lang PM, Fleckenstein J, Passmore GM, Brown DA, Grafe P (2008). Retigabine reduces the excitability of unmyelinated peripheral human axons. Neuropharmacology 54 : 1271 1278.
30. Logothetis DE, Jin T, Lupyan D, Rosenhouse-Dantsker A (2007). Phosphoinositide-mediated gating of inwardly rectifying K(+) channels. Pflugers Arch 455 : 83 95.
31. Madison DV, Nicoll RA (1984). Control of the repetitive discharge of rat CA 1 pyramidal neurones in vitro. J Physiol 354 : 319 331.
32. Main MJ, Cryan JE, Dupere JRB, Cox B, Clare JJ, Burbidge SA (2000). Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. Mol Pharmacol 58 : 253 262.
33. Maljevic S, Wuttke TV, Lerche H (2008). Nervous system KV7 disorders: breakdown of a subthreshold brake. J Physiol 586 : 1791 1801.
34. Marrion NV (1997). Control of M-current. Ann Rev Physiol 59 : 483 504.
35. Miceli F, Soloveri MV, Martire M, Taglialatela M (2008). Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs. Curr Opin Pharmacol 8 : 65 74.
36. Munro G, Erichsen HK, Mirza NR (2007). Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety. Neuropharmacology 53 : 609 618.
37. Otto JF, Kimball MM, Wilcox KS (2002). Effects of the anticonvulsant retigabine on cultured cortical neurons: changes in electroresponsive properties and synaptic transmission. Mol Pharmacol 61 : 921 927.
38. Pan Z, Kao T, Horvath Z, Lemos J, Sul JY, Cranstoun SD et al. (2006). A common ankyrin-G-based mechanism retains KCNQ and NaV channels at electrically active domains of the axon. J Neurosci 26 : 2599 2613.
39. Passmore GM, Brown DA (2007). Effects of M-channel modulators on peripheral excitability in rat hairy skin. Abstr Soc Neurosci 681 : 8.
40. Passmore GM, Selyanko AA, Mistry M, Al-Qatari M, Marsh SJ, Matthews EA, Dickenson AH, Brown TA, Burbidge SA, Main M, Brown DA (2003). KCNQ/M currents in sensory neurons: significance for pain therapy. J Neurosci 23 : 7236 7727.
41. Passmore GM, Robbins J, Abogadie F, Brown DA (2006). The KCNQ2 (Kv7.2) gene is required for functional M-channels in embryonic mouse superior cervical ganglion (SCG) neurons. Proc Physiol Soc 3 : C106.
42. Peretz A, Degani N, Nachman R, Uziyel Y, Gibor G, Shabat D et al. (2005). Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties. Mol Pharmacol 67 : 1053 1066.
43. Peretz A, Degani-Katzav N, Talmon M, Danieli E, Gopin A, Malka E, Nachman R, Raz A, Shabat O, Attali B (2007). A tale of switched functions: from cyclooxygenase inhibition to M-channel modulation in new diphenylamine derivatives. PLoSONE 2 : e1332.
44. Peters HC, Hu H, Pongs O, Storm JF, Isbrandt D (2005). Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior. Nat Neurosci 8 : 51 60.
45. Porter RJ, Partiot A, Sachdeo R, Nohria V, Alves WM (2007). Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures. Neurology 68 : 1197 1204.
46. Quinn KV, Behe P, Tinker A (2008). Monitoring changes in membrane phosphatidylinositol 4,5-bisphosphate in living cells using a domain from the transcription factor tubby. J Physiol 586 : 2855 2871.
47. Rasmussen HB, Frøkjaer-Jensen C, Jensen CS, Jensen HS, Jørgensen NK, Misonou H et al. (2007). Requirement of subunit co-assembly and ankyrin-G for M-channel localization at the axon initial segment. J Cell Sci 120 : 953 963.
48. Reeh PW (1986). Sensory receptors in mammalian skin in an in vitro preparation. Neurosci Letts 66 : 141 146.
49. Rivera-Arconada I, Lopez-Garcia JA (2006). Retigabine-induced population primary afferent hyperpolarisation in vitro. Neuropharmacology 51 : 756 763.
50. Robbins J (2001). KCNQ potassium channels: physiology, pathophysiology, and pharmacology. Pharmacol Ther 90 : 1 19.
51. Robbins J, Marsh SJ, Brown DA (2006). Probing the regulation of M(Kv7) channels in intact neurons with membrane-targeted peptides. J Neurosci 26 : 7950 7961.
52. Rockwood K, Beattie BL, Eastwood MR, Feldman H, Mohr E, Pryse-Phillips W et al. (1997). A randomized, controlled trial of linopirdine in the treatment of Alzheimer's disease. Can J Neurol Sci 24 : 140 145.
53. Roeloffs R, Wickenden AD, Crean C, Werness S, McNaughton-Smith G, Stables J et al. (2008). In vivo profile of ICA-27243 [N-(6-chloro-pyridin-3-yl)-3,4- difluoro-benzamide], a potent and selective KCNQ2/Q3 (Kv7.2/Kv7.3) activator in rodent anticonvulsant models. J Pharmacol Exp Ther 326 : 818 828.
54. Rostock A, Tober C, Rundfeldt C, Bartsch R, Engel J, Polymeropoulos EE et al. (1996). D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy Res 23 : 211 223.
55. Schenzer A, Friedrich T, Pusch M, Saftig P, Jentsch TJ, Grotzinger J et al. (2005). Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine. J Neurosci 25 : 5051 5060.
56. Schrøder RL, Jespersen T, Christophersen P, Strøbaek D, Jensen BS, Olesen SP (2001). KCNQ4 channel activation by BMS-204352 and retigabine. Neuropharmacology 40 : 888 898.
57. Schwarz JR, Glassmeier G, Cooper E, Kao T, Nodera H, Tabuena D et al. (2006). KCNQ channels mediate IKs, a slow K+ current regulating excitability in the node of Ranvier. J Physiol 573 : 17 34.
58. Selyanko AA, Sim JA (1998). Ca2+-inhibited non-inactivating K+ channels in cultured rat hippocampal pyramidal neurones. J Physiol 510 : 71 91.
59. Selyanko AA, Stansfeld CE, Brown DA (1992). Closure of potassium M-channels by muscarinic acetylcholine-receptor stimulants requires a diffusible messenger. Proc Biol Sci 250 : 119 125.
60. Selyanko AA, Hadley JK, Wood IC, Abogadie FC, Jentsch TJ, Brown DA (2000). Inhibition of KCNQ1-4 potassium channels expressed in mammalian cells via M1 muscarinic acetylcholine receptors. J Physiol 522 : 349 355.
61. Shah MM, Mistry M, Marsh SJ, Brown DA, Delmas P (2002). Molecular correlates of the M-current in cultured rat hippocampal neurons. J Physiol 544 : 29 37.
62. Shah MM, Migliore M, Valencia I, Cooper EC, Brown DA (2008). Functional significance of axonal Kv7 channels in hippocampal pyramidal neurons. Proc Natl Acad Sci USA 105 : 7869 7874.
63. Stocker M, Hirzel K, D'hoedt D, Pedarzani P (2004). Matching molecules to function: neuronal Ca2+-activated K+ channels and afterhyperpolarizations. Toxicon 43 : 933 949.
64. Suh BC, Hille B (2002). Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate synthesis. Neuron 35 : 507 520.
65. Suh BC, Horowitz LF, Hirdes W, Mackie K, Hille B (2004). Regulation of KCNQ21KCNQ3 current by G protein cycling: the kinetics of receptor-mediated signaling by Gq. J Gen Physiol 123 : 663 683.
66. Suh BC, Inoue T, Meyer T, Hille B (2006). Rapid chemically induced changes of PtdIns(4,5)P2 gate KCNQ ion channels. Science 314 : 1454 1457.
67. Tatulian L, Brown DA (2003). Effect of the KCNQ potassium channel opener retigabine on single KCNQ2/3 channels expressed in CHO cells. J Physiol 549 : 57 63.
68. Tatulian L, Delmas P, Abogadie FC, Brown DA (2001). Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. J Neurosci 21 : 5535 5545.
69. Wang HS, McKinnon D (1995). Potassium currents in rat prevertebral and paravertebral sympathetic neurones. J Physiol 485 : 319 337.
70. Wang HS, Pan Z, Shi W, Brown BS, Wymore RS, Cohen IS et al. (1998). KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 282 : 1890 1893.
71. Wang HS, Brown BS, McKinnon D, Cohen IS (2000). Molecular basis for differential sensitivity of KCNQ and I(Ks) channels to the cognitive enhancer XE991. Mol Pharmacol 57 : 1218 1223.
72. Wickenden AD, Yu W, Zou A, Jegla T, Wagoner PK (2000). Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. Mol Pharmacol 58 : 591 600.
73. Wickenden AD, Krajewski JL, London B, Wagoner PK, Wilson WA, Clark S et al. (2008). N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator. Mol Pharmacol 73 : 977 986.
74. Willars GB, Nahorski SR, Challis RAJ (1998). Differential regulation of muscarinic acetylcholine receptor-sensitive polyphosphoinositide pools and consequences for signaling in human neuroblastoma cells. J Biol Chem 273 : 5037 5046.
75. Winks JS, Hughes S, Filippov AK, Tatulian L, Abogadie FC, Brown DA et al. (2005). Relationship between membrane phosphatidylinositol-4,5-bisphosphate and receptor-mediated inhibition of native neuronal M channels. J Neurosci 25 : 3400 3413.
76. Wladyka CL, Feng B, Glazebrook PA, Schild JH, Kunze DL (2008). The KCNQ/M-current modulates arterial baroreceptor function at the sensory terminal in rats. J Physiol 586 : 795 802.
77. Wuttke TV, Seebohm G, Bail S, Maljevic S, Lerche H (2005). The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate. Mol Pharmacol 67 : 1009 1017.
78. Xiong Q, Sun H, Li M (2007). Zinc pyrithione-mediated activation of voltage-gated KCNQ potassium channels rescues epileptogenic mutants. Nat Chem Biol 3 : 287 296.
79. Xiong Q, Sun H, Zhang Y, Nan F, Li M (2008). Combinatorial augmentation of voltage-gated KCNQ potassium channels by chemical openers. Proc Natl Acad Sci USA 105 : 3128 3133.
80. Yamada W, Koch C, Adams P (1998). Multiple channels and calcium dynamics. In : Koch C, Segev L (eds). Methods in Neuronal Modelling: from Synapse to Networks, 2nd edn. MIT Press : Cambridge, MA, pp. 137 170.
81. Yue C, Yaari Y (2004). KCNQ/M channels control spike afterdepolarization and burst generation in hippocampal neurons. J Neurosci 24 : 4614 4624.
82. Zaika O, Lara LS, Gamper N, Hilgemann DW, Jaffe DB, Shapiro MS (2006). Angiotensin-II regulates neuronal excitability via PIP2-dependent modulation of Kv7 (M-type) potassium channels. J Physiol 575 : 49 67.
83. Zhang H, Craciun LC, Mirshahi T, Rohacs T, Lopes CM, Jin T et al. (2003). PIP(2) activates KCNQ channels, and its hydrolysis underlies receptor-mediated inhibition of M currents. Neuron 37 : 963 975.